ORPP logo

Allergy and Clinical Immunology. (Record no. 48839)

MARC details
000 -LEADER
fixed length control field 11477nam a22005413i 4500
001 - CONTROL NUMBER
control field EBC1998744
003 - CONTROL NUMBER IDENTIFIER
control field MiAaPQ
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729123518.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 240724s2015 xx o ||||0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781118609149
Qualifying information (electronic bk.)
035 ## - SYSTEM CONTROL NUMBER
System control number (MiAaPQ)EBC1998744
035 ## - SYSTEM CONTROL NUMBER
System control number (Au-PeEL)EBL1998744
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr11048181
035 ## - SYSTEM CONTROL NUMBER
System control number (CaONFJC)MIL769834
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)907965291
040 ## - CATALOGING SOURCE
Original cataloging agency MiAaPQ
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency MiAaPQ
Modifying agency MiAaPQ
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC584 -- .M68 2015eb
082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.97
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Sampson, Hugh A.
245 10 - TITLE STATEMENT
Title Allergy and Clinical Immunology.
250 ## - EDITION STATEMENT
Edition statement 1st ed.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Newark :
Name of producer, publisher, distributor, manufacturer John Wiley & Sons, Incorporated,
Date of production, publication, distribution, manufacture, or copyright notice 2015.
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice ©2015.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (491 pages)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Mount Sinai Expert Guides
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Intro -- Title Page -- Copyright Page -- Contents -- Contributors -- Series Foreword -- Preface -- List of Abbreviations -- About the Companion Website -- Part 1 Allergy -- Chapter 1 Atopic Dermatitis in Infants and Young Children -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis (Algorithm 1.1) -- Section 4: Treatment (Algorithm 1.2) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 2 Atopic Dermatitis in Teenagers and Adults -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis (Algorithm 2.1) -- Section 4: Treatment (Algorithm 2.2) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 3 Contact Dermatitis -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis (Algorithm 3.1) -- Section 4: Treatment (Algorithm 3.2) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 4 Allergic Rhinitis -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 5 Non-Allergic Rhinitis -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis (Algorithm 5.1) -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 6 Sinusitis -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 7 Allergic Diseases of the Eye -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis (Algorithm 7.1) -- Section 4: Treatment (Algorithm 7.2) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 8 Tests for Assessing Asthma -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 9 Asthma in Infants and Children -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 10 Asthma in Teenagers and Adults -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 11 Evaluation of Cough -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 12 Exercise-Induced Asthma -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 13 Occupational Asthma -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 14 Status Asthmaticus and Pending Pulmonary Failure -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis -- Section 4: Treatment (Algorithm 14.1) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 15 Evaluation of Food Allergy -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis (Algorithm 15.1) -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 16 Oral Allergy Syndrome -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis (Algorithm 16.1) -- Section 4: Treatment (Algorithm 16.2) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 17 Food Allergy and Atopic Dermatitis -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis (Algorithm 17.1) -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 18 Food Protein-Induced Enterocolitis Syndrome -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis (Algorithm 18.1) -- Section 4: Treatment (Algorithm 18.2).
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 19 Food Protein-Induced Proctocolitis Syndrome -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis (Algorithm 19.1) -- Section 4: Treatment (Algorithm 19.2) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 20 Eosinophilic Esophagitis -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis (Algorithm 20.1) -- Section 4: Treatment (Algorithm 20.2) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 21 Eosinophilic Gastroenteritis -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis (Algorithm 21.1) -- Section 4: Treatment (Algorithm 21.2) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 22 Food Allergy-Induced Anaphylaxis -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis -- Section 4: Treatment (Algorithm 22.1) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 23 Adverse Reactions to Food and Drug Additives -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis (Algorithm 23.1) -- Section 4: Treatment (Algorithm 23.2) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 9: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 24 Celiac Disease -- Section 1: Background.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Section 2: Prevention -- Section 3: Diagnosis (Algorithm 24.1) -- Section 4: Treatment (Algorithm 24.2) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 25 Oral Food Challenges (Procedure) -- Section 1: Indications -- Section 2: Procedure -- Section 3: Management of complications -- Section 4: Follow-up -- Section 5: Reading list -- Section 6: Guidelines -- Section 7: Evidence -- Section 8: Images -- Chapter 26 Acute Urticaria -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis -- Section 4: Treatment (Algorithm 26.1) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 27 Chronic Urticaria -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis (Algorithm 27.1) -- Section 4: Treatment (Algorithm 27.2) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 28 Hereditary Angioedema -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 29 Anaphylaxis -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis -- Section 4: Treatment (Algorithm 29.2) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence -- Section 10: Images -- Chapter 30 Mastocytosis -- Section 1: Background -- Section 2: Prevention -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Section 6: Prognosis.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on publisher supplied metadata and other sources.
590 ## - LOCAL NOTE (RLIN)
Local note Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Allergy.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunologic diseases.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunology.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Friedman, Scott L.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Main entry heading Sampson, Hugh A.
Title Allergy and Clinical Immunology
Place, publisher, and date of publication Newark : John Wiley & Sons, Incorporated,c2015
797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN)
Corporate name or jurisdiction name as entry element ProQuest (Firm)
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Mount Sinai Expert Guides
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=1998744">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=1998744</a>
Public note Click to View

No items available.

© 2024 Resource Centre. All rights reserved.